181 related articles for article (PubMed ID: 9657693)
1. Human cytomegalovirus protease complexes its substrate recognition sequences in an extended peptide conformation.
LaPlante SR; Aubry N; Bonneau PR; Cameron DR; Lagacé L; Massariol MJ; Montpetit H; Plouffe C; Kawai SH; Fulton BD; Chen Z; Ni F
Biochemistry; 1998 Jul; 37(27):9793-801. PubMed ID: 9657693
[TBL] [Abstract][Full Text] [Related]
2. Design of fluorogenic peptide substrates for human cytomegalovirus protease based on structure-activity relationship studies.
Bonneau PR; Plouffe C; Pelletier A; Wernic D; Poupart MA
Anal Biochem; 1998 Jan; 255(1):59-65. PubMed ID: 9448842
[TBL] [Abstract][Full Text] [Related]
3. Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease.
Tong L; Qian C; Massariol MJ; Déziel R; Yoakim C; Lagacé L
Nat Struct Biol; 1998 Sep; 5(9):819-26. PubMed ID: 9731777
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel peptide substrate of HSV-1 protease using substrate phage display.
O'Boyle DR; Pokornowski KA; McCann PJ; Weinheimer SP
Virology; 1997 Sep; 236(2):338-47. PubMed ID: 9325241
[TBL] [Abstract][Full Text] [Related]
5. Structural and kinetic analysis of caspase-3 reveals role for s5 binding site in substrate recognition.
Fang B; Boross PI; Tozser J; Weber IT
J Mol Biol; 2006 Jul; 360(3):654-66. PubMed ID: 16781734
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a soluble stable human cytomegalovirus protease and inhibition by M-site peptide mimics.
LaFemina RL; Bakshi K; Long WJ; Pramanik B; Veloski CA; Wolanski BS; Marcy AI; Hazuda DJ
J Virol; 1996 Jul; 70(7):4819-24. PubMed ID: 8676515
[TBL] [Abstract][Full Text] [Related]
7. In vitro proteolytic activity and active-site identification of the human cytomegalovirus protease.
Stevens JT; Mapelli C; Tsao J; Hail M; O'Boyle D; Weinheimer SP; Diianni CL
Eur J Biochem; 1994 Dec; 226(2):361-7. PubMed ID: 8001553
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional structure of human cytomegalovirus protease.
Shieh HS; Kurumbail RG; Stevens AM; Stegeman RA; Sturman EJ; Pak JY; Wittwer AJ; Palmier MO; Wiegand RC; Holwerda BC; Stallings WC
Nature; 1996 Sep; 383(6597):279-82. PubMed ID: 8805708
[TBL] [Abstract][Full Text] [Related]
9. Evidence of a conformational change in the human cytomegalovirus protease upon binding of peptidyl-activated carbonyl inhibitors.
Bonneau PR; Grand-Maître C; Greenwood DJ; Lagacé L; LaPlante SR; Massariol MJ; Ogilvie WW; O'Meara JA; Kawai SH
Biochemistry; 1997 Oct; 36(41):12644-52. PubMed ID: 9376371
[TBL] [Abstract][Full Text] [Related]
10. Cleavage specificity of human rhinovirus-2 2A protease for peptide substrates.
Wang QM; Sommergruber W; Johnson RB
Biochem Biophys Res Commun; 1997 Jun; 235(3):562-6. PubMed ID: 9207196
[TBL] [Abstract][Full Text] [Related]
11. Thrombin-bound structures of designed analogs of human fibrinopeptide A determined by quantitative transferred NOE spectroscopy: a new structural basis for thrombin specificity.
Ni F; Zhu Y; Scheraga HA
J Mol Biol; 1995 Oct; 252(5):656-71. PubMed ID: 7563081
[TBL] [Abstract][Full Text] [Related]
12. Thrombin activity is unaltered by N-terminal truncation of factor XIII activation peptides.
Isetti G; Maurer MC
Biochemistry; 2004 Apr; 43(14):4150-9. PubMed ID: 15065858
[TBL] [Abstract][Full Text] [Related]
13. In vitro processing of HIV-1 nucleocapsid protein by the viral proteinase: effects of amino acid substitutions at the scissile bond in the proximal zinc finger sequence.
Tözsér J; Shulenin S; Louis JM; Copeland TD; Oroszlan S
Biochemistry; 2004 Apr; 43(14):4304-12. PubMed ID: 15065874
[TBL] [Abstract][Full Text] [Related]
14. Probing thrombin's ability to accommodate a V34F substitution within the factor XIII activation peptide segment (28-41).
Isetti G; Maurer MC
J Pept Res; 2004 Mar; 63(3):241-52. PubMed ID: 15049836
[TBL] [Abstract][Full Text] [Related]
15. Human cytomegalovirus maturational proteinase: expression in Escherichia coli, purification, and enzymatic characterization by using peptide substrate mimics of natural cleavage sites.
Burck PJ; Berg DH; Luk TP; Sassmannshausen LM; Wakulchik M; Smith DP; Hsiung HM; Becker GW; Gibson W; Villarreal EC
J Virol; 1994 May; 68(5):2937-46. PubMed ID: 8151764
[TBL] [Abstract][Full Text] [Related]
16. Functional determinants of the Epstein-Barr virus protease.
Buisson M; Valette E; Hernandez JF; Baudin F; Ebel C; Morand P; Seigneurin JM; Arlaud GJ; Ruigrok RW
J Mol Biol; 2001 Aug; 311(1):217-28. PubMed ID: 11469870
[TBL] [Abstract][Full Text] [Related]
17. Substrate specificity of the Escherichia coli outer membrane protease OmpT.
McCarter JD; Stephens D; Shoemaker K; Rosenberg S; Kirsch JF; Georgiou G
J Bacteriol; 2004 Sep; 186(17):5919-25. PubMed ID: 15317797
[TBL] [Abstract][Full Text] [Related]
18. The P1' specificity of tobacco etch virus protease.
Kapust RB; Tözsér J; Copeland TD; Waugh DS
Biochem Biophys Res Commun; 2002 Jun; 294(5):949-55. PubMed ID: 12074568
[TBL] [Abstract][Full Text] [Related]
19. ADAM33 enzyme properties and substrate specificity.
Zou J; Zhang R; Zhu F; Liu J; Madison V; Umland SP
Biochemistry; 2005 Mar; 44(11):4247-56. PubMed ID: 15766253
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the substrate specificity of two potyvirus proteases.
Tözsér J; Tropea JE; Cherry S; Bagossi P; Copeland TD; Wlodawer A; Waugh DS
FEBS J; 2005 Jan; 272(2):514-23. PubMed ID: 15654889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
